DRUG · Unmapped registry intervention
SPARC1210
Find medicine records ·
Find other trials using this name
Clinical trial
Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer
NCT02136927
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Reference1210
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
SPARC1210DRUG
Reference1210DRUG
Sponsors & collaborators
Sun Pharma Advanced Research Company Limitedlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02136927 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.